Download the appMore options
PisaczekSearch
文AEN-US
Vitamins and mineralsStudies updated this month

High-dose vitamin C—a medicine you won't hear about at the doctor's office?

Sources: 16 · Article: 18 664 characters ↓

What do Natural Therapy Specialists write?

Andrzej Frydrychowski

For a life-threatening infection, Andrzej Frydrychowski recommends intravenous doses of 40 to 200 g of vitamin C per day and claims that this kind of administration is prohibited.

„In the case of an infection that poses a threat to life—for example, sepsis or a severe viral infection—vitamin C should be administered intravenously at doses ranging from 40 g to as much as 200 g per day. The only mistake we can make is giving too small a dose of the vitamin. And here is the problem: intravenous administration at these doses is prohibited.”W razie infekcji, przy której mamy zagrożenie życia – np. sepsa czy silna infekcja wirusowa – należy podawać wit. C dożylnie w dawkach od 40 g do nawet 200 g/dobę. Jedynym błędem, który możemy popełnić, jest podawanie witaminy w zbyt małej dawce. I tutaj pojawia się problem. Podawanie dożylne w takich dawkach jest zabronione.
Jerzy Zięba

High doses of vitamin C were presented as possible support in severe viral respiratory infections.

„To counter this, it has been shown that giving high doses of vitamin C (ascorbic acid or ascorbate), in addition to standard conventional supportive therapies, is a safe and effective treatment in severe cases of viral respiratory infection.”Aby temu przeciwdziałać, wykazano, że podawanie dużych dawek witaminy C (kwasu askorbinowego lub askorbinianu), oprócz standardowych konwencjonalnych terapii wspomagających, jest bezpieczną i skuteczną terapią w ciężkich przypadkach wirusowego zakażenia dróg oddechowych.
Jerzy Zięba

High-dose vitamin C was presented as possible immune support that may limit complications and shorten the course of a viral infection.

„To effectively fight the new SARS-CoV-2 virus, doctors should investigate readily available pharmaceutical and nutritional treatments with proven antioxidant, anti-inflammatory, and immunosuppressive properties. Supplementary vitamin C may also provide additional benefits in preventing viral infections, shortening the course of illness, and reducing complications—source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553131/.”Aby skutecznie walczyć z nowym wirusem SARS-CoV-2, lekarze powinni zbadać łatwo dostępne farmaceutyczne i odżywcze środki terapeutyczne o udowodnionych właściwościach przeciwutleniających, przeciwzapalnych i immunosupresyjnych. Uzupełniająca witamina C może również zapewnić dodatkowe korzyści w zapobieganiu infekcjom wirusowym, skrócić przebieg choroby i zmniejszyć powikłania choroby – źródło: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7553131/.
Andrzej Frydrychowski

During an infection, Andrzej Frydrychowski recommends 2 g of vitamin C every three hours and intravenous administration in life-threatening situations.

„At the time of an infection, the body's need for this vitamin increases dramatically. That is why we must then give as much as 2 g every 3 hours, until the infection has passed. In the case of an infection that poses a threat to life—for example, sepsis or a severe viral infection—vitamin C should be given.”W momencie infekcji zapotrzebowanie na tę witaminę rośnie drastycznie. Dlatego wtedy musimy ją podawać nawet po 2 g co 3 godziny, aż do ustąpienia infekcji. W razie infekcji, przy której mamy zagrożenie życia – np. sepsa czy silna infekcja wirusowa – należy podawać wit.
Jerzy Zięba

High intravenous doses were described as promising for treating COVID-19, but it was also noted that vitamin C does not cure.

„From the article you will learn that vitamin C does not cure, and you will also learn that high doses of vitamin C given intravenously are promising for treating COVID-19. Does that sound familiar? The article is dated October 13, 2020. It was published 7 months after I presented to you, in March, the information I had gathered about methods of treating COVID-19 and substances that, in doctors' opinion, should be used in medical procedures.”Z artykułu dowiecie się, że witamina C nie leczy, jak również dowiecie się, że wysokie dawki witaminy C podawane dożylnie są obiecujące w leczeniu COVID-19. Coś Wam to mówi? Artykuł jest z 13 października 2020 roku. Został opublikowany 7 miesięcy po tym jak w marcu przedstawiłem Wam zebrane informacje na temat metod leczenia COVID-19 i substancji, które zdaniem lekarzy powinny być wykorzystywane w procedurach medycznych.
Jerzy Zięba

For kidney problems, Jerzy Zięba recommends using vitamin C cautiously and slowly, preferably under a doctor's supervision.

„However, these forms of vitamin C have half the ability to neutralize free radicals—which is what we are aiming for in every case—compared with ascorbic acid. Since vitamin C is water-soluble, the kidneys quickly remove any excess. If someone has kidney problems, caution and very slow use of vitamin C are recommended—preferably under a doctor's supervision.”Przy czym zdolność neutralizowania wolnych rodników tymi formami witaminy C (a o taką neutralizację nam chodzi w każdym przypadku) jest o połowę mniejsza, niż w przypadku zastosowania kwasu askorbinowego. Ponieważ witamina C jest rozpuszczalna w wodzie, nerki szybko wydalają jej nadmiar. Jeśli ktoś ma problemy z nerkami, zaleca się ostrożność i bardzo powolne stosowanie witaminy C – najlepiej pod kontrolą lekarza.
Andrzej Frydrychowski

Andrzej Frydrychowski cites claims about intravenous vitamin C being used to treat several infections, including a 1 g dose for malaria.

„Giving only 1 g of vitamin C intravenously caused chills to stop immediately, reduced the fever, and improved the patient's general condition (Lotze 1938). Readers will probably object that the literature is from the last century. That is true, because vitamin C was used and permitted in those years.”Podanie tylko 1 g witaminy C dożylnie spowodowało natychmiastowe ustępowanie dreszczy, spadek gorączki oraz ogólną poprawę samopoczucia (Lotze 1938). Czytelnik pewnie zarzuci, że literatura jest z tamtego wieku. Owszem, ponieważ w tamtych latach witamina C była stosowana i dozwolona.
Jerzy Zięba

Intravenous vitamin C given together with chemotherapy to nine patients was described as a treatment for advanced pancreatic cancer.

„This treatment was used in 9 patients with advanced pancreatic tumors. They received intravenous vitamin C for a month while undergoing chemotherapy. The disease did not progress in their bodies for six months after the treatment ended. We need more experiments, studies, and publications like this.”Tę metodę leczenia zastosowano u 9 pacjentów z zaawansowanym guzem trzustki. Przy stosowaniu chemioterapii, podawano im przez miesiąc witaminę C dożylnie. Choroba nie poczyniła postępów w ich organizmach w ciągu pół roku od zakończenia kuracji. Aby więcej takich eksperymentów i badań, a także publikacji.

What does scientific research from PubMed · Europe PMC say?

We selected 9 studies with the best, positive results. This is a selection, not a full review of all research.

Total number of studies on this topic in PubMed: 2 621.

Aim of the study: Acute respiratory tract infections (ARIs) are a leading cause of ill-health and death globally. Individual or multiple micronutrients have been shown to modulate immune function and affect the risk and severity of a number of infectious diseases.

Results: The effect of vitamin C on preventing ARI was stronger among men and in middle-income countries, compared with women and high-income countries, respectively. Zinc supplementation did not reduce the risk of ARIs but shortened the duration of symptoms substantially (per cent difference: -47% (95% CI -73% to -21%; p=0.0004)). Our synthesis of global evidence from randomised controlled trials indicates that micronutrient supplements including zinc, vitamins C and D, and multiple micronutrient supplements may be modestly effective in preventing ARIs and improving their clinical course. Further research is warranted to better understand the effectiveness that individual or multiple micronutrients have on SARS-CoV-2 infection and treatment outcomes.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studycombined analysis of many studies (meta-analysis)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Vitamin C (VitC) is known to directly impair cancer cell growth in preclinical models, but there is little clinical evidence on its antitumoral efficacy. In addition, whether and how VitC modulates anticancer immune responses is mostly unknown.

Results: High-dose VitC modulates infiltration of the tumor microenvironment by cells of the immune system and delays cancer growth in a T cell-dependent manner. VitC not only enhances the cytotoxic activity of adoptively transferred CD8 T cells but also cooperates with immune checkpoint therapy (ICT) in several cancer types. Combination of VitC and ICT can be curative in models of mismatch repair-deficient tumors with high mutational burden. This work provides a rationale for clinical trials combining ICT with high doses of VitC.

Money for the studygovernment, public institutions
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Tendinopathy is an aging-related disease, often caused by micro-scarring and degeneration due to overuse or trauma. Ascorbic acid (vitamin C) supplementation is reported to be a useful treatment for tendinopathy recovery.

Results: The cytoskeleton was maintained in the HC group but not in the C group. qPCR analysis revealed that p16 expression was inhibited in both the C and HC groups compared to the H2O2 group; other markers had increased expression. The progression of cell death and cytoskeletal disruption was inhibited by the administration of high-dose vitamin C. Hence, high-dose vitamin C is a potential treatment for tendon cell degeneration.

Money for the studygovernment, public institutions · The Ministry of Education, Culture, Sports, Science, and Technology of Japan, Kanazawa Medical University
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studylaboratory study (on cells)

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Radiation-induced pulmonary fibrosis (RIPF) is a frequently encountered late complication in patients undergoing radiation therapy, presenting a substantial risk to patient mortality and quality of life. The pathogenesis of RIPF remains unclear, and current treatment options are limited in efficacy.

Results: In order to explore the mechanism by which high-dose vitamin C attenuates RIPF, we utilized RNA-seq analysis of mouse lung tissue in conjunction with publicly available databases. Our findings indicated that high-dose vitamin C inhibits the differentiation of fibroblasts into myofibroblasts by targeting S100A8 and S100A9 derived from neutrophils. Additionally, the combination of high-dose vitamin C and radiation demonstrated enhanced inhibition of tumor growth in a murine LLC tumor model. These results revealed that the combination of radiotherapy and high-dose vitamin C may offer a promising therapeutic approach for the clinical management of thoracic tumors and the prevention of RIPF.

Money for the studygovernment, public institutions · National Natural Science Foundation of China
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Acute kidney injury frequently occurs after cardiac surgery, and is primarily attributed to renal ischemia-reperfusion (I/R) injury and inflammation from surgery and cardiopulmonary bypass. Vitamin C, an antioxidant that is often depleted in critically ill patients, could potentially mitigate I/R-induced oxidative stress at high doses.

Results: Doses of 100 and 200 mg/kg during reperfusion reduced oxidative stress markers, including myeloperoxidase and inflammatory responses by decreasing high mobility group box 1 release and nucleotide-binding and oligomerization domain-like receptor 3 inflammasome. Overall beneficial effect was most prominent with 200 mg/kg. The 300 mg/kg dose, however, showed no additional benefits over the IRC group regarding serum blood urea nitrogen and creatinine levels and histological evaluation. During reperfusion, high-dose vitamin C administration (200 mg/kg) significantly decreased renal I/R injury by effectively attenuating the major triggers of oxidative stress and inflammation.

Money for the studygovernment, public institutions · National Research Foundation of Korea, Yonsei University College of Medicine
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: KRAS mutations are frequently observed in human cancer and are associated with proliferation, therapy-resistance and worse outcome. Regrettably, only a fraction of possible mutations is druggable.

Results: Obviously we do not know whether this response could have also been observed if chemotherapy was given w/o high-dose vitamin C. As up to now two randomized clinical trials showed a beneficial effect of the addition of high-dose vitamin C (pancreatic cancer: Bodeker et al., colorectal cancer: Vitality trial), and, in the case of Vitality, the benefit was restricted to KRAS mutated tumors only, more clinical trials addressing this topic are needed. Therefore, we thank Bodeker et al. for contributing these important data.

Money for the studyuniversity or foundation · José Carreras Leukämie-Stiftung, Deutsche Forschungsgemeinschaft, Philipps-Universität Marburg
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyother
Participants1

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: The adjunctive therapeutic value of vitamin C in sepsis or septic shock patients remains controversial. This study aimed to evaluate the therapeutic efficacy and safety of intravenous administration of vitamin C in sepsis or septic shock patients through meta-analysis.

Results: Fourteen randomized controlled trials enrolling 1,958 patients were eligible for assessment. Meta-analysis demonstrated that intravenous vitamin C reduced 28-day mortality in sepsis or septic shock patients compared to the control group (RR 0.70; 95% CI 0.53 to 0.93; P = 0.02; I 2 = 52%), based on low quality of evidence, and subgroup analysis showed the benefit was driven by single-center studies, not observed in multicenter trials. Vitamin C shortened the duration of vasopressor use (SMD = -0.42, 95% CI -0.77 to -0.08, P = 0.02) and was associated with a greater reduction in SOFA score (MD = -1.04, 95% CI -1.83 to -0.25, P = 0.01), but did not reduce vasopressor dose, length of stay, or 24-h urine output. No significant adverse events were reported. This meta-analysis suggests that intravenous vitamin C might be associated with reduced mortality in sepsis, but the benefit was not confirmed in low-risk-of-bias multicenter trials and was primarily driven by single-center studies.

Money for the studynot stated
Do the authors have ties to companies?no — the authors say so
Did a manufacturer help with the study?NO
Type of studyreview of many studies

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: Background: High-dose intravenous vitamin C (IVC) and mistletoe therapy are widely used in palliative care as complementary interventions to relieve symptoms and improve quality of life. However, prospective evidence regarding their impact on overall survival in breast cancer remains limited.

Results: In multivariable time-dependent Cox regression analysis, high-dose IVC therapy (HR: 0.561, 95% CI: 0.319-0.986, p = 0.045) and mistletoe therapy (HR: 0.463, 95% CI: 0.231-0.927, p = 0.030) were independently associated with significantly reduced overall mortality risk. Hyperthermia therapy showed no significant association with mortality after multivariable adjustment (HR: 1.497, 95% CI: 0.794-2.820, p = 0.212). Conclusions: High-dose IVC and mistletoe therapies were independently associated with lower overall mortality in female breast cancer patients. These findings support further investigation of these modalities as potential integrative adjuncts to standard care.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyobservation of people
Participants748

“Not stated” does not mean nobody paid — the database does not always record it.

Aim of the study: High-dose vitamin C (vitC) has shown superior anticancer activity in immunocompetent compared with immunodeficient mice, suggesting an immunodependent mechanism of action.

Results: This was accompanied by substantial remodeling of the tumor microenvironment, including increased infiltration of cytotoxic CD8⁺ T cells and natural killer cells, and a reduction in immunosuppressive regulatory T cells. Blocking calreticulin effectively disrupted the ICD cascade, prevented immune microenvironment remodeling, and completely abrogated the antitumor efficacy of vitC. Collectively, our study indicates that high-dose vitC promotes ICD by mobilizing calreticulin and HMGB1, and that calreticulin is a determinant of its immune-mediated antitumor activity. Implications: vitC induces ICD, supporting its use as an adjuvant to anticancer immunotherapy.

Money for the studynot stated
Do the authors have ties to companies?not stated
Did a manufacturer help with the study?unknown
Type of studyanimal study

“Not stated” does not mean nobody paid — the database does not always record it.

What do orthomolecular medicine doctors write?

Orthomolecular Medicine News Service
„We know high-dose vitamin C may have pro-oxidant activity, but if the dosage is too high (And what defines too high?), would this add a pro-oxidant effect to an already elevated oxidative stress? With protocols specifying 30-50 grams of IVC, how can this dose be scientifically justified? Further, the existing data from many decades of studies show that oral vitamin C can prevent viral infection. It would be helpful for an NIH panel to further study the prevention of COVID-19 with oral vitamin C by pushing the oral dose higher. COVID-19 infection seems to linger around for a longer time than the common cold.”We know high-dose vitamin C may have pro-oxidant activity, but if the dosage is too high (And what defines too high?), would this add a pro-oxidant effect to an already elevated oxidative stress? With protocols specifying 30-50 grams of IVC, how can this dose be scientifically justified? Further, the existing data from many decades of studies show that oral vitamin C can prevent viral infection. It would be helpful for an NIH panel to further study the prevention of COVID-19 with oral vitamin C by pushing the oral dose higher. COVID-19 infection seems to linger around for a longer time than the common cold.
Orthomolecular Medicine News Service
„10 February 13, 2020 Coronavirus Patients in China to be Treated with High-Dose Vitamin C Les patients atteints de coronavirus en Chine seront traités avec une forte dose de vitamine C Coronavirus-Patienten in China sollen mit hochdosiertem Vitamin C behandelt werden Vol. 16, No. 09 February 10, 2020 VITAMIN C AND ITS APPLICATION TO THE TREATMENT OF nCoV CORONAVIRUS: How Vitamin C Reduces Severity and Deaths from Serious Viral Respiratory Diseases LA VITAMINE C ET SON APPLICATION DANS LE TRAITEMENT du CORONAVIRUS nCoV Vitamin C und seine Anwendung zur Therapie des nCov-Coronavirus Vol. 16, No.”10 February 13, 2020 Coronavirus Patients in China to be Treated with High-Dose Vitamin C Les patients atteints de coronavirus en Chine seront traités avec une forte dose de vitamine C Coronavirus-Patienten in China sollen mit hochdosiertem Vitamin C behandelt werden Vol. 16, No. 09 February 10, 2020 VITAMIN C AND ITS APPLICATION TO THE TREATMENT OF nCoV CORONAVIRUS: How Vitamin C Reduces Severity and Deaths from Serious Viral Respiratory Diseases LA VITAMINE C ET SON APPLICATION DANS LE TRAITEMENT du CORONAVIRUS nCoV Vitamin C und seine Anwendung zur Therapie des nCov-Coronavirus Vol. 16, No.

Sources (16)

Pisaczek does not judge who is right. It shows what was written and where to read it. Every sentence above has its source.